Chen Y, Chen B, Wu T et al (2023) Cryo-EM structure of human -opioid receptor-Gi complex bound to an endogenous agonist dynorphin A
B12 injections for weight loss capture the attention of the modern world because they combine valid scientific evidence with increasing popularity despite the abundant diet fads and so-called miracle supplements all the time filling social media feeds
The "minimal initial benefit" group (approximately 5-10% of users) reported limited improvements during treatment making discontinuation effects irrelevant, typically explained by inadequate product quality with degraded or low-concentration GHK-Cu, inappropriate application technique reducing absorption, unrealistic expectations exceeding what any topical can achieve, severe underlying pathology requiring medical intervention beyond cosmetic peptides, or individual non-responsiveness to copper peptide treatment for genetic or physiological reasons
GHK-Cu serum is currently the focus of this buzz, with compelling scientific backing
People with liver disease, kidney issues, or certain allergies should consult a doctor before use
No claims are made regarding medical, therapeutic, or clinical outcomes
